Time-Restricted Eating Helps to Improve Diabetes Outcomes
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 13, 2024 -- Time-restricted eating (TRE) may improve diabetes outcomes, independent of energy intake, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 9 to 13 in Madrid.
K.A. Bowden Davies, from Manchester Metropolitan University in the United Kingdom, and colleagues examined the effects of TRE in a eucaloric manner, comparing early (ETRE; 8:00-16:00 hours) versus late (LTRE; 12:00-20:00 hours) conditions on habitual (free)-living glycemic control in 15 overweight sedentary adults. In the crossover study, each phase lasted three days.
The researchers found that compared with habitual eating (>14 hours/day), TRE (eight hours/day) significantly increased time spent in euglycemia by 3.3 percent (P < 0.001) and reduced mean absolute glucose by 0.6 mmol/L (P = 0.003), coefficient of variation by 2.6 percent (P < 0.001), and mean amplitude of glucose excursions by 0.4 mmol/L (P = 0.020). There was no significant effect for ETRE versus LTRE (P > 0.05). Habitual calorie intake and macronutrient composition were similar to TRE (P > 0.05).
“Our findings, which can be attributed to the 16-hour fasting window rather than the time of eating or changes in energy intake, highlight the benefit of TRE in only three days,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
WEDNESDAY, May 28, 2025 -- For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related...
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.